Exploiting proteomic data for genome annotation and gene model validation in Aspergillus niger by Wright, JC et al.
Exploiting proteomic data for genome annotation and gene model
validation in Aspergillus niger
Wright, JC; Sugden, D; Francis-McIntyre, S; Riba-Garcia, I; Gaskell, SJ; Grigoriev, IV; Baker,
SE; Beynon, RJ; Hubbard, SJ
 
 
 
 
 
 
 
For additional information about this publication click this link.
https://qmro.qmul.ac.uk/jspui/handle/123456789/141
 
 
 
Information about this research object was correct at the time of download; we occasionally
make corrections to records, please therefore check the published record when citing. For
more information contact scholarlycommunications@qmul.ac.uk
BioMed Central
Page 1 of 14
(page number not for citation purposes)
BMC Genomics
Open AccessResearch article
Exploiting proteomic data for genome annotation and gene model 
validation in Aspergillus niger
James C Wright1,2, Deana Sugden3, Sue Francis-McIntyre3, Isabel Riba-
Garcia3, Simon J Gaskell3, Igor V Grigoriev4, Scott E Baker5, Robert J Beynon1 
and Simon J Hubbard*2
Address: 1Dept Veterinary Preclinical Sciences, University of Liverpool, Crown Street, Liverpool, L69 7ZJ, UK, 2Faculty of Life Sciences, University 
of Manchester, Manchester, M13 9PT, UK, 3MBCMS, MIB, University of Manchester, Manchester, M13 9PT, UK, 4DOE Joint Genome Institute, 
2800 Mitchell Drive, Walnut Creek, CA 94598, USA and 5Pacific Northwest National Laboratory, 902 Battelle Blvd, Richland, WA 99354, USA
Email: James C Wright - james.wright@manchester.ac.uk; Deana Sugden - deena.sugden@manchester.ac.uk; Sue Francis-
McIntyre - sue.mcintyre@manchester.ac.uk; Isabel Riba-Garcia - isabel.riba@manchester.ac.uk; 
Simon J Gaskell - simon.gaskell@manchester.ac.uk; Igor V Grigoriev - IVGrigoriev@lbl.gov; Scott E Baker - scott.baker@pnl.gov; 
Robert J Beynon - r.beynon@liverpool.ac.uk; Simon J Hubbard* - simon.hubbard@manchester.ac.uk
* Corresponding author    
Abstract
Background: Proteomic data is a potentially rich, but arguably unexploited, data source for
genome annotation. Peptide identifications from tandem mass spectrometry provide prima facie
evidence for gene predictions and can discriminate over a set of candidate gene models. Here we
apply this to the recently sequenced Aspergillus niger fungal genome from the Joint Genome
Institutes (JGI) and another predicted protein set from another A.niger sequence. Tandem mass
spectra (MS/MS) were acquired from 1d gel electrophoresis bands and searched against all available
gene models using Average Peptide Scoring (APS) and reverse database searching to produce
confident identifications at an acceptable false discovery rate (FDR).
Results: 405 identified peptide sequences were mapped to 214 different A.niger genomic loci to
which 4093 predicted gene models clustered, 2872 of which contained the mapped peptides.
Interestingly, 13 (6%) of these loci either had no preferred predicted gene model or the genome
annotators' chosen "best" model for that genomic locus was not found to be the most
parsimonious match to the identified peptides. The peptides identified also boosted confidence in
predicted gene structures spanning 54 introns from different gene models.
Conclusion: This work highlights the potential of integrating experimental proteomics data into
genomic annotation pipelines much as expressed sequence tag (EST) data has been. A comparison
of the published genome from another strain of A.niger sequenced by DSM showed that a number
of the gene models or proteins with proteomics evidence did not occur in both genomes, further
highlighting the utility of the method.
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Background
Post genomic research and systems biology have greatly
expanded our knowledge and understanding of biological
processes, fuelled by the growth in sequenced genomes
and accompanying technological developments. These
techniques, such as microarray-based transcriptomics and
proteomics, are reliant on the high quality annotation of
newly sequenced genomes. Indeed, this heavy depend-
ency on a sequenced genome or cDNA library can often be
limiting in the scope of studies, particularly for non
model organisms [1]. However, functional genomics
experiments on sequenced organisms can also play an
important role in defining or re-evaluating the genome
sequenced on which they are based. Experimental data
can be fed back into the genome to help demonstrate the
validity or otherwise of the original gene structure predic-
tions or to assist the annotation of new genomes.
Many genome sequencing projects use a range of in silico
prediction methods to generate a large, and sometimes
highly redundant, set of possible open reading frames
(ORFs) and gene structure models. A good example is the
pipeline employed by the widely-used Ensembl genome
browser [2]. Here, a combination of EST, cDNA, orthol-
ogy and statistical data are used to derive gene sets which
are reconciled to produce a final set of high quality pre-
dicted genes. A further example is provided by recent fun-
gal genomes sequenced at the US DOE Joint Genome
Institute (JGI) whereby a large set of gene models are pro-
duced, typically with several candidates for each locus.
Further analyses reduce this to a smaller filtered set of
"best" gene predictions via a second layer of bioinformatic
methods, manual annotation and the use of experimental
data. It is one such example, that of Aspergillus niger, which
forms the basis for this study. A. niger is a common asco-
mycete fungus that acts as an opportunistic human path-
ogen, however, it is generally more commonly known for
its use in industrial biotechnological applications such as
the production of citric acid [3]. We wished to apply mass
spectrometry-based proteomics on A. niger as an exemplar
system with which to test the utility of proteomics to
refine and process a recently sequenced and annotated
genome and produce an even higher quality gene set.
There have already been several studies of the proteomics
of filamentous fungi, now that there are several complete
genome sequences, and this technique is being widely
applied to understand fungal biology [4].
Although cDNA and oligonucleotides arrays can demon-
strate that a predicted gene is expressed [5,6] and tiling
arrays can define exon-intron structure with exquisite
accuracy [7], they still focus on the un-translated mRNA.
Proteomics provides a higher level confirmation of gene
expression and is beginning to be used in genome anno-
tation [8-10]. Mass spectrometry (MS) is an effective and
fast method for identifying proteins from their constitu-
ent peptides and recent developments support much
higher coverage of the commonly expressed proteome
[11-13]. For example, Aerbersold and colleagues demon-
strated how the PeptideAtlas database could be exploited
to map many thousands of peptides back on to the
human proteome [14,15]. Similarly, cDNA/EST data and
mass spectrometry experiments have been used to identify
novel ORFs and splice variants. Peptide identifications in
expressed sequence tags (ESTs) [16] or expressed peptide
tags (ePSTs) [17,18] were matched back to the genomic
scaffolds, thereby identifying or validating real ORFs.
Experimental proteomic data can therefore help with the
prediction and validation of predicted gene structure and
there are a growing number of examples which have
helped annotate translational start sites, exons and SNPs
[19,20,8]. In parallel, informatic proteome pipelines are
also becoming more "genome-centric". Examples include
the genome annotating pipeline (GAPP) [21] and Pepti-
deAtlas resources [14,15] which both support the map-
ping of identified peptides back onto genome viewers
[22]. Some experiments have even found these published
genomes are annotated incorrectly [23] fully demonstrat-
ing the utility of proteome data. These conclusions have
sparked interest throughout both proteomics and genom-
ics as to the best ways in which to use this new source of
experimental validation of genome annotations [9].
In this project we collected tandem MS data from A. niger
samples and searched this against predicted protein
sequences derived from two independent genome
sequences: ATCC1015 http://www.jgi.doe.gov/aspergillus
by JGI and CBS 513.88 by DSM [24]. The JGI sequence in
particular had 87,287 predicted gene models, containing
11,200 "best" models, which we clustered to 8709
genomic loci (Table 1). To generate peptide identifica-
tions, tandem MS data was searched against forwards and
reversed protein sequence databases derived from the JGI
and DSM model sets using Mascot [25]. As well as using
standard Mascot scoring, we used a modified version of
the Average Peptide Scoring (APS) technique which itera-
tively calculates peptide filters and reverse database
thresholds [26] at various false discovery rates (FDR). By
filtering out low scoring peptides using a threshold score
Table 1: Overview of JGI and DSM A. niger genome data
DOE JGI A. niger genome
Genome Size 37.1 Mb
Number of Gene Models generated 87,287
Number of filtered "best" Gene Models 11,200
DSM A. niger genome
Genome Size 33.9 Mb
Number of annotated proteins 14,165
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this method claims to find more confident protein identi-
fications than the standard Mascot (v2.1) protocol. The
APS-identified peptides were then mapped back to the
genome via the gene models clustered at each locus. This
data offers direct support for predicted open reading
frames for two independent A. niger genome annotations.
For the JGI annotation, the MS data provides support for
conflicting gene model predictions and can potentially
eliminate inconsistent ones from further consideration.
For a significant number of clusters, gene models not hith-
erto considered the "best" were seen to be more consistent
with the experimental data, suggesting they are more
likely to be correct or be the principally expressed isoform.
This pilot project further demonstrates the utility of pro-
teome data for genome annotation, since it can be used to
experimentally validate predicted gene model sets and
offer an additional source of evidence that a gene is not
only transcribed, but also translated.
Methods
Experimental Aspergillus niger proteomics
Aspergillus culture conditions and protein extraction
Aspergillus niger strain N402 was cultured in Aspergillus
media (ACM) at 25°C and 150 rpm. The A. niger mycelia
(100 mg) were ground down using a pestle and mortar
and cells lysed by mechanical glass bead cell lysis. Protein
was then extracted using TCA precipitation.
1-D Electrophoresis
A. niger extracts were separated on 10%, 12% and 15%
SDS-PAGE gels and stained using Coomassie R250. Gel
bands were excised from top to bottom of the gel. In-gel
tryptic digestion was carried out as described by
Shevchenko et al [27] and the resulting peptides were
extracted by the addition of 2 volumes of Acetronitrile and
dried prior to analysis.
LC-MS/MS
Liquid Chromatography tandem mass spectrometry (LC-
MS/MS) was performed on an UltiMate/Switchos/Famos
nanoflow HPLC (Dionex, Camberley, Surrey) coupled to a
QTof I (Waters, Manchester). Prior to analysis, dried sam-
ples were redissolved in 6 μl of 0.1% formic acid (v/v). 5
μl of each sample was injected and desalted on a trapping
column (PepMap C18, 300 m i.d., 5 mm length) prior to
separation on PepMap C18 analytical column (75 m i.d.,
15 cm length). Using a 200 nl/min 1 h gradient: 5–90%
solvent B (A = 2% Acetonitrile, 0.06% formic acid; B = 95%
Acetonitrile, 0.05% formic acid, v/v). Data-dependent
switching between MS and MS/MS acquisition was used,
with product ion spectra recorded for a maximum of three
precursors per cycle.
Peak lists (.pkl files) were generated using PeptideAuto in
MassLynx 3.4 software (Waters), combining all sequential
scans for the same precursor, centroiding data with a min-
imum peak width parameter of 2 and using a peak top
parameter of 80%.
Computational Aspergillus niger proteomics
Data sources
The main source of data for this project was downloaded
from the JGI Genome Portal for A.niger http://
www.jgi.doe.gov/aspergillus and included the genomic
scaffolds, the unfiltered set of gene models generated
autonomously in the JGI annotation pipeline and also the
filtered gene models set. The size of each of these sets is
displayed in Table 1 along with statistics for another
A.niger genome recently sequenced industrially by DSM
Food Specialties http://www.dsm.com/en_US/html/dfs/
genomics_aniger.htm and recently published [24].
Generation of gene models
Gene models in the genome of Aspergillus niger were pre-
dicted using ab initio gene predictor Fgenesh [28] and
homology-based methods Fgenesh+ [28] and Genewise
[29]. In addition over 15,000 A.niger ESTs from GenBank
and over 1,200 full-length (FL) mRNAs from RefSeq were
directly mapped to genomic sequence and were employed
to extend the predicted gene models into FL genes by add-
ing 5' and/or 3' UTRs using the estExt method. Since mul-
tiple gene models were generated for each locus, a single
representative model from each set of overlapping gene
models was selected. This selection was based on homol-
ogy to proteins from other organisms and available EST
support. Gene models overlapping with transposable ele-
ments detected in the A.niger assembly were excluded
from the final set. All these methods are integrated into
the JGI annotation pipeline. Finally the initial redundant
set of 87,287 gene models predicted by different methods
was filtered down to a non-redundant set of 11,200 "best"
gene models.
Mass spectrometry database searching
The resulting spectra from the MS analysis of the A.niger
samples were submitted to a local Mascot server (version
2.1) [25] and searched against both the forwards and
reversed versions of each FASTA-formatted protein
sequence databank, generated from the JGI and DSM gene
model datasets. All Mascot searches used the following
parameters: a precursor ion tolerance of 2 Da, fragment
ion tolerance of 0.5 Da, a miss cleavage allowance of up
to and including 2, and oxidation of methionine residues
as a variable modification. Searches were carried out inde-
pendently for each band cut from the gel. Mascot search
results were also further processed using a local imple-
mentation of the Average Peptide Scoring (APS) method
[26], applying both a peptide quality filter (set to a mini-
mum ion score of 10) and a protein-level APS threshold
derived from spectral matches to peptides in a reversed
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decoy database. (see Figure 1). The APS is calculated as the
average peptide score over all putative peptide hits for a
candidate protein match. Using a reverse database it is
possible to calculate a false discovery rate (FDR) from
matches to the forwards and decoy (reverse) database
above a given APS protein threshold. The original method
implemented by Shadforth and colleagues reported all
"forward" protein matches above the maximum APS score
which is calculated from the reverse database search
results (treating single and multi-peptide protein hits
independently). This equates to a theoretical 0% FDR,
although this model has its limitations [26,30]. We have
made modifications to this approach as it led to some
inconsistencies when applied to our dataset of highly
redundant protein models and notably where relatively
small numbers of spectra were obtained from some gel
bands. The latter case led to artificially low maximum
Mascot ion and APS scores derived from the reverse data-
base searches, which in turn led to weak identifications
being reported. To avoid this, we calculated APS thresh-
olds using the combined reverse database results from all
gel bands, again treating single and multi-peptide protein
identifications separately. This provides a better back-
ground model to estimate chance spectral matches and
leads to more conservative APS thresholds. We also
applied a more realistic FDR threshold of 2%, calculating
false positives from the reverse database hits using the
equation below:
Where FP is the number of false positive reverse protein
hits above the APS threshold, and TP the number of for-
ward protein hits above the threshold less the number of
false positives. For example, if 100 forward proteins and 5
reverse proteins exceed the APS threshold, TP = 100 - 5, FP
= 5, and FDR = 5/(95+5) = 5%. As the reverse database hits
were taken from all searches, the FP values were scaled by
the relative number of spectra in each band. The APS pro-
tein threshold was lowered until the FDR reached 2%. For
each gel band we calculated the optimal peptide score
threshold by increasing it from a value of 10 in steps of 1
and calculating the number of APS forward hits at the 2%
FDR threshold. The peptide score threshold reporting the
largest number of APS hits was used.
FDR
FP
TP FP
=
+
Schematic of the Average Peptide Scoring (APS) pipeline using reversed database searchingFigure 1
Schematic of the Average Peptide Scoring (APS) pipeline using reversed database searching. The final APS 
threshold is established iteratively for each pkl file searched against a given database, calculated over a range of peptide quality 
filters. Mascot was used to conduct an initial database search of both forward and reverse databases, and the resulting peptide 
scores were then used to calculate an average peptide score for matching proteins.
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All mass spectrometry data and peptide identifications
have been deposited with the PRIDE proteomics database
http://www.ebi.ac.uk/pride, with PRIDE accessions
7972–8124 inclusive.
Clustering of the gene models
At the project outset, complete genomic coordinates were
not available for the JGI predicted protein dataset. Hence,
as an extra quality control step, all gene models were
mapped back to the genomic scaffold using EXONER-
ATE[31] from the European Bioinformatics Institute (EBI)
http://www.ebi.ac.uk/~guy/exonerate/. These were subse-
quently found to be in agreement with genomic coordi-
nates. Mapped gene models were then grouped into
clusters in a simple fashion based on overlapping
genomic coordinates (See Figure 2).
Analysis of the gene models clusters with proteomics data
For searches conducted against the JGI predicted pro-
teome set from the gene models, each peptide identified
as significant using the APS scoring method pipeline was
mapped back though the matched gene models to the
appropriate genomic scaffold. Gene clusters were then
evaluated by ranking the clustered gene models in a tabu-
lar format based on the number of peptides matched in
the genomic region. Each gene model cluster and affili-
ated peptides were also visualised using the BioP-
erl::Graphics module [32]. The peptide data matched and
aligned to each cluster of gene models allowed the elimi-
nation of inconsistent models from the cluster. This
allowed the clusters to be classified into four categories: i)
clusters with no matched proteomics data, ii) clusters con-
taining a "best" filtered model which is consistent with all
aligned peptides, iii) clusters which do not contain a
Overview of the relationship between gene models, clusters and predicted proteinsFigure 2
Overview of the relationship between gene models, clusters and predicted proteins. An overview of how Aspergil-
lus niger proteomics data is mapped via clusters of gene models, which are in turn mapped back to the genomic scaffold via 
EXONERATE. This allowed the assessment and evaluation of gene models located at a particular genomic loci based on the pep-
tides consistent with the proposed gene model structures.
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"best" filtered model but match some proteomics data,
and iv) clusters containing a "best" filtered model which
is inconsistent with the proteomics data. Categories iii)
and iv) are of particular interest since they support novel
gene structures not deemed the most likely from the gene
prediction pipeline.
Results and discussion
Average Peptide Scoring (APS) Results
All 19,628 MS/MS spectra collected from digestions of
153 gel slices from 3 separate runs were searched against
the various A. niger proteome databases. Spectra collected
from individual gel slices were searched against the vari-
ous protein databases separately, rather than combining
spectra from all bands, since peptide identifications com-
mon to one slice were more likely to come from the same
protein. Table 2 compares the numbers of peptide identi-
fications made using both "standard" Mascot searching
and the Average Peptide Scoring (APS) protocol [26]. All
peptide, protein and cluster-centric data are available in
Additional File 1.
The APS search results are compared to two interpreta-
tions of direct Mascot searching. Mascot(1) simply reports
the number of proteins containing one or more peptides
with ion scores above Mascot's default threshold, which
estimates significance at p < 0.05 for individual peptides.
Mascot(2) results refer to Mascot's MudPit scoring system,
the recommended approach when considering large num-
bers of spectra, which filters out some low scoring pep-
tides. Mascot did not find large numbers of significant
protein hits to the reverse databases in this case (typically
only 1 or 2 proteins for each experiment). It should be
noted that the current version of Mascot (v2.2) also sup-
ports reverse database searching directly although we per-
formed equivalent searches here "manually" with the
earlier version.
The data presented here provides still further evidence
that the APS technique is a simple yet effective strategy to
find peptide hits consistent with confident protein-level
identifications whilst maintaining a low overall false dis-
covery rate. As noted by Shadforth and colleagues [26],
the APS approach removes candidate false positive hits
whilst maximising true positive matches by selecting
weaker scoring peptides that are consistent with higher
scoring peptides in the same proteins. This is broadly
equivalent to Mascot's MudPIT scoring system which
effectively removes protein hits from multiple low scoring
peptide matches.
Table 2 shows results for the two protein sequence data-
bases derived from the JGI genome. The first contained all
the automatically generated gene models and the second
a reduced set of filtered gene models representing the
most likely protein, where appropriate, for each gene
locus. The "All Models" database is highly redundant con-
taining 87,287 gene models, and is almost eight times the
size of the filtered dataset. This leads to the greater
number of APS matches compared to the filtered set; con-
sequently there is also redundancy in these protein
matches and the number of hits to the filtered database
gives a better reflection of the total number of identified
proteins from different gene loci. In mitigation, the Mascot
significance threshold is dependent on database size and
consequently the larger "All Models" database has a
higher peptide and protein threshold for reporting signif-
icant matches.
Table 2: Protein-level identifications obtained over three search databases.
JGI Genes
All modelsa
(87,287)
JGI Genes
Filtered modelsb (11,200)
DSM proteins
(14,165)
Gel01–12% SDS (partial) 8 bands APS hits 638 42 40
Mascot hits(1)c 461 38 36
Mascot hits(2)d 448 38 36
Gel02–15% SDS (partial) 33 bands APS hits 1443 109 111
Mascot hits(1)c 1062 102 102
Mascot hits(2)d 1047 102 102
Gel03–10% SDS (full) 110 bands APS hits 2349 153 156
Mascot hits(1)c 1572 146 140
Mascot hits(2)d 1572 146 139
aSearches performed against 87,287 protein sequences translated from 87,287 predicted gene models, cluster at 8709 loci on the genome.
aSearches performed against the 11,200 "best" gene models, based on homology to known proteins, from the full 87,287 set. Note, some clusters 
have more than one "best" model, and some have none, hence there are more "best" models than clusters.
cProtein hits are reported with 1 or more peptide identification with significant Mascot scores (p < 0.05)
dProtein hits are reported with 1 or more peptide identification with significant scores using the Mascot MudPit Score.
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The APS scoring method calculates separate thresholds for
single and multi peptide identifications [26] and typically
for most high throughput proteomics studies, a large pro-
portion of our peptide identifications were "one hit won-
ders". Although these matches are generally held to be of
lesser confidence than multi-peptide matches, other
authors have argued against this [33] and the APS meth-
odology does consider them independently with a more
stringent threshold (the average multi-peptide APS filter
was a Mascot ion score of 34, whereas the single peptide
equivalent was 51). Whilst we recognise that the
approaches used here are unlikely to completely remove
all false positive identifications, we reasoned that a small
false positive rate was tolerable for gene model validation
where other sources of information may also used. We
conducted some further tests to boost confidence in these
single peptide identifications, searching them back
against the genome sequence using tblastn (with no low
complexity filtering, and expect value, word size, and
database size parameters optimised for short matches). In
total, 95.5% of these 149 peptides align to the genome
only once (in the original predicted locus), indicating that
the majority are indeed unique and not chance matches to
another mis-predicted sequence. Although this does not
guarantee the Mascot identification of the peptide
sequence, this does at least reassure us that given a correct
peptide identification, there is no ambiguity in placement
on the genome sequence. The few peptides that were
unmatched were observed to span introns and could not
be matched by using a simple tblastn search where the
large "gap" was not spanned.
We also examined the relationship between the theoreti-
cal mass of the matched A. niger proteins and gel band
position of the protein identifications from the 10% gel.
A histogram of protein identifications collated by ordered
gel band is compared to an aligned histogram of the aver-
age protein mass identified in each band; an example is
displayed in Figure 3. As the 1-dimensional SDS-PAGE gel
separates proteins based on their mass it is therefore
expected that most protein identifications should be
localised to a small number of neighbouring bands on the
gel. Indeed, over 25% of the identified proteins were
unique to a single, specific gel band, with a majority of the
identifications shared within a 10 gel band range; indeed
most of these were within 5 gel bands. Only a small
number of identifications were shared over large distances
across the gel. Some of these could be false positive iden-
tifications, although it is also possible that truncated gene
model predictions, paralogues, alternative isoforms or
post-translational modifications could lead to different
gel migration properties for some proteins. For example,
closely related protein homologues in the same gene fam-
ily will be indistinguishable from each other if only a
small number of common peptide identifications are
available.
Overall, these results are generally reassuring since the
proteins used here represent a range of predicted gene
models and there is a clear trend in decreasing protein
mass down the gel. A high false positive rate would lead
to many protein identifications outside of the expected
mass range, decreasing the correlation with average mass
shown in Figure 3. A simple correlation of average protein
mass against gel band number results in a Pearson corre-
lation of 0.94, which supports this. This is considerably
higher than would be expected by chance (p < 10-20) with
a mean correlation of 0.01 (s.d. 0.1) obtained by shuffling
the protein masses in a simulation. Similar results are
obtained when searching against either the JGI filtered
gene set or DSM gene set (data not shown) suggesting
there is no bias produced by a given gene set.
Mapping of proteomics data to gene model clusters
The complete set of 87,297 JGI A.niger gene models were
mapped back to the genome using EXONERATE to gener-
ate 8709 overlapping clusters, some of which span multi-
ple genes. The clusters were then filtered, limiting the set
to those which contained peptide mappings from the pro-
teomics data. These 214 clusters contained 4093 individ-
ual gene models of which 2872 were supported by
matched peptide data. As can be seen in Table 3, the 214
models were further classified into 3 categories. The first
and most prevalent were those clusters containing a
model from the JGI filtered "best" dataset which was itself
supported by the proteomics experimental evidence. The
second category contained proteomic evidence, but no
model from the filtered "best" dataset mapped to that
genomic locus – sufficient evidence to assign a preferred
gene model was not available at this locus. Finally, the
third category contained clusters that did contain a fil-
tered "best" model but this model was unsupported by
the proteomic data whereas an alternative, conflicting,
model was. This suggests an alternative gene structure for
this locus is more likely. The first category provides exper-
imental validation that the "best" gene model in that clus-
ter is the most representative at the given genomic locus
and if nothing else increases confidence in those models.
The later two categories covered 13 of the JGI clusters,
each one suggesting either an addition or alteration to the
filtered "best" model dataset. In total this represents over
6% of all gene clusters with accompanying proteomic
data. However, even though the proteomics data boosts
confidence in individual gene models and suggests altera-
tions to the filtered set of "best" models, the total peptide
coverage on many of these gene models is often poor. This
does not therefore provide conclusive validation of a par-
ticular gene model over another; rather it offers additional
support at the protein level that a particular isoform is
BMC Genomics 2009, 10:61 http://www.biomedcentral.com/1471-2164/10/61
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expressed from that particular genomic locus. This is anal-
ogous to the use of ESTs/cDNAs to lend weight to gene
predictions; absence of transcriptional data does not in
itself disprove a candidate gene model, but when direct
physical evidence of a different gene structure at the same,
over-lapping, locus is observed it reduces the confidence
that it is correct or the principal expressed isoform in
those experimental conditions.
Putting the peptide identification data in to the context of
our results, we examined the 4093 models in the 214 gene
clusters with associated APS peptide matches. Of these,
1221 of the models were classified as inconsistent with
the proteomic data, which represents about 30% of them.
This is, on average around 5 models per cluster; clusters
contain 16 models on average.
Gel band protein identifications and their relationship with theoretical molecular weightFigure 3
Gel band protein identifications and their relationship with theoretical molecular weight. The right hand bar chart 
shows of the number of protein identifications made from each gel slice using the average peptide scoring method when 
searching the DSM A. niger database. Dark green sections represent protein identifications unique to that gel band. Subsequent 
colours, shown in the key at the top of the plot, indicate the distance in consecutive gel bands that a particular set of protein 
identifications are shared i.e. red shows protein identifications which are found more than 10 bands from the current positions. 
The left hand bar chart shows the mean protein mass in KDa for proteins identified in each gel band. As should be expected 
the average protein mass decreases from the top to the bottom of the gel.
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One of the most informative types of peptide identifica-
tion involves those that spanned an intron/exon bound-
ary. We matched 54 peptides spanning introns. These
identifications provide proteomics evidence for predicted
splice sites in the gene models above and beyond any
available transcript data or orthologues.
Further analysis of gene model clusters
We analysed the 13 unusual JGI clusters in more detail,
additionally comparing them with the genes predicted in
the DSM genome sequence, and reporting BLAST matches
from the UniRef90 database. Results are shown in Table 4.
In all but one case, a homologous gene is predicted in the
DSM annotation and a UniProt homologue is detected
with a highly significant e-value of 10-30 or better in
another species. This lends weight and consistency to their
validity as genuine protein coding genes.
We also generated a visual representation of each of the
214 clusters using the BioPerl::Graphics module, with
each gene model and its significant peptides aligned to the
genomic scaffold. This allowed us to manually investigate
each cluster to see exactly how our proteomics evidence
supports certain gene model structures over others. Figure
4 contains 4 example clusters with associated peptide
identifications and illustrates the cluster redundancy with
considerable similarity in the different gene models pre-
dicted from the various pipelines. The examples shown in
Figure 4 are typical with similar exonic structure through-
out; most of the variation between gene models occurs in
the terminal regions. Cluster 523_S5:
scaffold_5:2102252-2101542 (example A, Figure 4) maps
a single peptide to a cluster of just three gene models. In
this case, the gene predictions have identified a "best" fil-
tered model (shown in yellow) as well as two further can-
didates. The proteomics data offers direct positive
evidence that the two non filtered models are more likely.
This is due to the peptide spanning a predicted intron at
the C-terminus of the models, which is absent in the fil-
tered model. This cluster represents a Calmodulin protein
from sequence similarity searches against UniRef90 and
DSM databases. The P1 peptide, AVDTSSGEINYTDLVR,
which distinguishes the predicted JGI models, is also con-
sistent with the DSM predicted protein as shown in Figure
5a. All alternative models including the filtered model
read through this section of the genome and do not con-
tain an intron.
The second example, cluster 68_S6: Scaffold_6: 215962–
216777 shows 5 peptides clearly supporting the filtered
model and validating one of the three introns in the gene
models. These gene modes show strong similarity to ubi-
quinone reductase in other filamentous fungi. Three of
the peptides are clustered close together at the C-terminus
and one at the N-terminus, two areas of the gene models
that can be very difficult to validate and correctly predict.
Figure 5 shows a more detailed look at how the peptides
clearly match the terminal regions of the predicted gene
models.
Finally, example cluster 78_S17:scaffold_17:300012-
298397, which shows similarity to Aspartate aminotrans-
ferase, does contain a "best" filtered model which matches
all the peptide data. The models in the cluster are similar
with all the predicted structural differences occurring
around one particular intron which is validated by one of
the peptides. This cluster is supported by a large number
of proteome peptides which gives good coverage of the
models validating the key intron where the predictions
differ. These examples provide a clear demonstration of
Table 3: Gene cluster and proteome peptide identification results.
Number of APS matches (to 
Gene clusters, Proteins, or 
Peptides)
i) "Best" filtered model 
consistent with peptide 
data
ii) Gene cluster does not 
contain a "Best" filtered model, 
but does have APS matches
iii) "Best" filtered model in 
cluster is inconsistent with 
peptide data
Gene Clusters 214 201 9 4
Protein identifications
Total 2872 2729 56 87
Single peptide 1791 1698 28 65
Multi-peptide 1081 1031 28 22
Peptide identifications
Unique 405 379 13 13
(single peptide hits) (149)
(multi-peptide hits) (256)
(Identified peptides validating exon/intron boundaries: 54 peptides covering 54 introns)
Of the 8709 gene model clusters generated only 214 contained individual gene models with significant APS scores. These 214 clusters were then 
classified into three distinct types; a). those where all peptide identifications were consistent with the filtered gene model selected as the best 
model for that particular genomic locus, b). those where the cluster did not include a "best" filtered model but still contained models with matching 
peptide identifications, and c). those clusters where the "best" filtered model either did not match or other models in the cluster were more 
parsimonious with the proteomics data suggesting that the filtered model was not the most likely model for that particular gene locus.
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Table 4: Gene cluster statistics where "best" filtered model is inconsistent with proteome peptide data
Cluster ID DSM E-Value DSM Protein DSM Protein Description UniRef
E Value
UniRef Protein UniRef Protein Description
68_S6 2E-64 An15g00690 strong similarity to 14.8 kD 
subunit of NADH:ubiquinone 
reductase – Neurospora 
crassa
2E-54 Q1E404 Hypothetical protein; n = 1; 
Coccidioides immitis RS|Rep: 
Hypothetical protein – 
Coccidioides immitis RS
229_S11 5E-41 An09g03480 strong similarity to snRNA-
associated sm-like protein 
Lsm2 – Saccharomyces 
cerevisiae
8E-35 Q1E7Q6 Hypothetical protein; n = 1; 
Coccidioides immitis RS|Rep: 
Hypothetical protein – 
Coccidioides immitis RS
626_S3 4E-71 An08g03600 similarity to hypothetical 
protein CAE47874.1/
AfA24A6.130c – Aspergillus 
fumigatus
3E-47 Q0D146 Predicted protein; n = 1; 
Aspergillus terreus 
NIH2624|Rep: Predicted protein 
– Aspergillus terreus NIH2624
25_S5 0 An07g09990 strong similarity to heat shock 
protein 70 hsp70 – 
Ajellomyces capsulatus 
[putative frameshift]
0 Q56G95 Heat shock protein 70; n = 2; 
mitosporic Trichocomaceae|Rep: 
Heat shock protein 70 – 
Penicillium marneffei
523_S5 1E-75 An07g01640 strong similarity to calmodulin 
6 CaM6 – Arabidopsis thaliana
7E-70 Q4WGR4 EF-hand protein; n = 2; 
Aspergillus|Rep: EF-hand protein 
– Aspergillus fumigatus 
(Sartorya fumigata)
303_S2 1E-37 An02g05240 strong similarity to histone 4 
from patent WO9919502-A1 
– Homo sapiens
8E-38 UPI00005A5829 PREDICTED: similar to germinal 
histone H4 gene; n = 1; Canis 
familiaris|Rep: PREDICTED: 
similar to germinal histone H4 
gene – Canis familiaris
117_S3 2E-131 An06g00990 strong similarity to soluble 
cytoplasmic fumarate 
reductase YEL047c – 
Saccharomyces cerevisiae
2E-71 Q0CC76 Hypothetical protein; n = 1; 
Aspergillus terreus 
NIH2624|Rep: Hypothetical 
protein – Aspergillus terreus 
NIH2624
54_S17 9E-139 An04g06870 similarity to hypothetical 
protein CAD21072.1 – 
Neurospora crassa
2E-121 Q4WPR6 Transcription factor RfeF, 
putative; n = 1; Aspergillus 
fumigatus|Rep: Transcription 
factor RfeF, putative – 
Aspergillus fumigatus 
(Sartorya fumigata)
717_S2 0 An02g11680 strong similarity to translation 
initiation factor eIF-4A – 
Schizosaccharomyces pombe
0 Q5B948 ATP-dependent RNA helicase 
eIF4A; n = 1; Emericella 
nidulans|Rep: ATP-dependent 
RNA helicase eIF4A – Emericella 
nidulans (Aspergillus nidulans)
39_S9 5E-72 An12g09130 similarity to glucanase 
ZmGnsN3 from patent 
WO200073470-A2 – Zea 
mays
7E-130 Q4WCP3 Hypothetical protein; n = 1; 
Aspergillus fumigatus|Rep: 
Hypothetical protein – 
Aspergillus fumigatus 
(Sartorya fumigata)
373_S9 No Match 0 Q2TZ90 Ca2+binding actin-bundling 
protein; n = 2; Aspergillus|Rep: 
Ca2+binding actin-bundling 
protein – Aspergillus oryzae
256_S9 3E-125 An12g04870 strong similarity to cytoplasmic 
ribosomal protein of the large 
subunit L10 – Saccharomyces 
cerevisiae
1E-117 Q2TZP5 RIB40 genomic DNA, SC011; n = 
2; Aspergillus|Rep: RIB40 
genomic DNA, SC011 – 
Aspergillus oryzae
238_S10 2E-124 An18g04220 strong similarity to 
mitochondrial ADP/ATP 
carrier anc1p – 
Schizosaccharomyces pombe
4E-115 Q4WJN2 Mitochondrial ADP, ATP carrier 
protein (Ant), putative; n = 1; 
Aspergillus fumigatus|Rep: 
Mitochondrial ADP, ATP carrier 
protein (Ant), putative – 
Aspergillus fumigatus 
(Sartorya fumigata)
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Example Gene Clusters with associated peptide identificationsFigure 4
Example Gene Clusters with associated peptide identifications. Three example mappings of proteomics data to clus-
ters via the gene models are shown. The images, generated using the BioPerl::Graphics module, are split into tracks with the 
top ruler representing the genomic scaffold and the first track coloured black highlighting the region covered by the cluster. 
The tracks below this represent all the gene models mapped to this cluster regardless of whether they have proteomics evi-
dence or not. The yellow models correspond to those that are included in the filtered "best" gene model set; models not in the 
filtered set are coloured green. The final and bottommost track represents the peptides as mapped to the genome track and 
are coloured blue. Each example shows how the proteomics evidence in the form of significantly matched peptides can lend 
weight to support or refute the filtered gene model set.
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how proteomic evidence can support and refine gene
models predicted from sequenced genomes, lend weight
to predictions and help reconcile different potential gene
structures in the annotation process.
Comparison of DSM and JGI genomes
Another strain of A. niger has also been recently sequenced
and published by DSM [22] and we compared the col-
lected proteome data here using Mascot searches against
both the DSM and JGI predicted protein sets, shown in
Table 2 and Figure 3. Using a simple reciprocal top-hit
BLAST approach we defined equivalence relationships
between the DSM proteins and the JGI gene models. As
would be expected, both protein datasets have a propor-
tion of proteins with no similarity in the other database,
and we have proteomics evidence for some of these
unique proteins. In fact 9 DSM proteins had significant
APS peptide identifications but had no corresponding
gene model in the JGI dataset and, vice-versa, 130 JGI gene
models (corresponding to 18 distinct clusters) with pro-
teomic data had no equivalent protein in the DSM data-
base. This suggests that some possible gene models have
not yet been generated for the JGI genome which would
fit into the "best" filtered dataset and also that several pro-
teins have been missed in the DSM annotation which are
included in the JGI gene models set.
Conclusion
Proteomics would not be possible without genomics;
however, this does not mean that it is powerless to assist
genomics. In fact quite the contrary, proteomics provides
a fast, relatively cheap and confident method for gather-
ing a large amount of experimental evidence to assist
genome annotation. It also has the added advantage of
confirming that transcripts are translated to the proteome
stage and can help identify functional details of the
mature protein form which includes N- and C-termini
and post-translational modifications. Here we present a
relatively modest scale study on a fungal organism of cur-
rent interest and hence our data has a relatively limited
coverage of the entire A. niger proteome. Recent publica-
tions point out the need to conduct multiple high
throughput experiments under a variety of conditions to
achieve complete proteome coverage [34] and we have
only used one here. Despite this, and using a "hot off the
press" genome annotation, we were able to offer pro-
teomic support for 214 genes with proteomic data offer-
ing refinements to predicted gene models in around 6% of
these cases. These represent 13 gene predictions for which
there was uncertainty in the annotation (no filtered
model) or were potentially incorrectly annotated in the
original gene model selection process. Importantly, as
some of the examples in Figure 4 highlight, there is often
uncertainty surrounding the true N- and C-termini of
Example gene cluster alignmentsFigure 5
Example gene cluster alignments. Selected sections from the examples in Figure 4 are shown as alignments illustrating 
peptide mappings to the gene models. Peptide identifications are shown in shaded boxes, corresponding to those in Figure 4, 
with intron spanning peptides linked by a solid line. The "best" filtered models are shown in bold text, the corresponding 
aligned DSM proteins in purple, and gene models consistent with the proteomics data are preceded by an asterisk.
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genes and most of the variability in the gene model struc-
tures exists at these regions. We were able to offer concrete
data to help resolve some of these ambiguities in a
number of cases, but it should be noted that we have not
employed a targeted strategy to protein termini here. One
attractive potential solution would be to use an N-termi-
nal specific peptide preparation to enrich for the peptides
[35].
We believe that this feedback of experimental data into
genomic annotation pipelines could well be formalised
and assist in gene prediction pipelines, as has been
recently been demonstrated for Arabidopsis [36]. Proteom-
ics has the advantage of providing direct evidence for gene
products rather than any intermediate stage in the tran-
scription process, and the field has been slow to incorpo-
rate proteomics data formally into gene prediction
models. However, we hope that this work and others
offers strong support for its inclusion, using MS-based
peptide identifications as a similar line of evidence to
ESTs.
A further point of caution is also necessary. In Aspergillus,
the level of alternative splicing that occurs has yet to be
fully characterised, but appears to be modest [37]. In most
cases, the choice for gene prediction is therefore which of
the candidate models is most consistent with the data and
most likely to be correct. For species exhibiting higher lev-
els of splicing, with multiple isoforms from a single locus,
it is more challenging to interpret the data. Multiple pep-
tide identifications could belong to two or more isoforms
and it is quite possible that several isoforms are present in
the same sample, especially when multiple tissues are
studied.
One final caveat that concerns many in the proteomics
field is the "one hit wonder" syndrome [33] – proteins
with only a single confident peptide identification.
Although the majority of our peptide identifications were
not in this category, they are still more likely to be false
positives. Using the APS approach with independent
thresholds for single peptide matches attempts to put
them on a consistent protein level confidence to the
multi-peptide hits. Indeed, the APS threshold was higher
for single peptide hits (51 compared to 34 on average).
However, more work is clearly needed to convince prac-
tioners of their validity, but appropriately weighted and
considered they can offer genuine experimental evidence
to support gene models as we have demonstrated here.
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